The news of a potential class action lawsuit against Novo Nordisk A/S (NVO) is likely to have a negative short-term impact on its stock price as it raises legal and financial uncertainties. Shareholders are encouraged to seek recovery options, indicating potential issues with the company's past disclosures or performance.